Works matching DE "DOCETAXEL"
Results: 3368
Predictive factors for failure of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy in esophageal squamous cell carcinoma.
- Published in:
- Diseases of the Esophagus, 2025, v. 38, n. 1, p. 1, doi. 10.1093/dote/doae115
- By:
- Publication type:
- Article
Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma.
- Published in:
- Diseases of the Esophagus, 2025, v. 38, n. 1, p. 1, doi. 10.1093/dote/doae114
- By:
- Publication type:
- Article
Adapalene potentiates the cytotoxicity of anti-cancer drugs by enhancing cell cycle dysregulation and apoptosis in MKN-45 cells.
- Published in:
- Toxicology Research, 2025, v. 14, n. 1, p. 1, doi. 10.1093/toxres/tfaf017
- By:
- Publication type:
- Article
Docetaxel Micelles: A New Formulation to Diminish Hypersensitivity Reactions.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 184, doi. 10.3390/pharmaceutics17020184
- By:
- Publication type:
- Article
Sialic acid-modified docetaxel cationic liposomes: double targeting of tumor-associated macrophages and tumor endothelial cells.
- Published in:
- Journal of Liposome Research, 2025, v. 35, n. 1, p. 29, doi. 10.1080/08982104.2024.2388140
- By:
- Publication type:
- Article
MANAGEMENT OF CARCINOMA OF BREAST WITH DOCETAXEL CHEMOTHERAPY.
- Published in:
- Malaysian Journal of Medical Sciences, 2008, p. 71
- By:
- Publication type:
- Article
Therapie des kastrationsrefraktären Prostatakarzinoms.
- Published in:
- 2012
- By:
- Publication type:
- Report
Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.
- Published in:
- Current Medical Literature: Urology, 2008, v. 14, n. 3, p. 64
- Publication type:
- Article
CITATIONS AND CLINICIANS' NOTES: PROSTATE CANCER.
- Published in:
- 2005
- Publication type:
- Abstract
Citations and Clinicians' Notes: Prostate Cancer.
- Published in:
- Current Medical Literature: Urology, 2003, v. 9, n. 4, p. 114
- Publication type:
- Article
Establishment and characterization of a canine soft tissue sarcoma patient-derived xenograft model.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 754, doi. 10.1111/vco.12215
- By:
- Publication type:
- Article
Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.
- Published in:
- Veterinary & Comparative Oncology, 2014, v. 12, n. 2, p. 160, doi. 10.1111/j.1476-5829.2012.00350.x
- By:
- Publication type:
- Article
Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats.
- Published in:
- Veterinary & Comparative Oncology, 2003, v. 1, n. 2, p. 105, doi. 10.1046/j.1476-5829.2003.00015.x
- By:
- Publication type:
- Article
Radiolabeled Polymeric Nanoconstructs Loaded with Docetaxel and Curcumin for Cancer Combinatorial Therapy and Nuclear Imaging.
- Published in:
- Advanced Functional Materials, 2015, v. 25, n. 22, p. 3371, doi. 10.1002/adfm.201500627
- By:
- Publication type:
- Article
Docetaxel Modulates the Delayed Rectifier Potassium Current ( I) and ATP-Sensitive Potassium Current ( I) in Human Breast Cancer Cells.
- Published in:
- Journal of Membrane Biology, 2015, v. 248, n. 2, p. 197, doi. 10.1007/s00232-014-9757-6
- By:
- Publication type:
- Article
Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.
- Published in:
- Surgery Today, 2017, v. 47, n. 10, p. 1249, doi. 10.1007/s00595-017-1512-z
- By:
- Publication type:
- Article
Expression of BRCA1, a factor closely associated with relapse-free survival, in patients who underwent neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil for squamous cell carcinoma of the esophagus.
- Published in:
- Surgery Today, 2017, v. 47, n. 1, p. 65, doi. 10.1007/s00595-016-1338-0
- By:
- Publication type:
- Article
A Phase II Study of Weekly Docetaxel for Patients with Advanced or Recurrent Cancer of the Cervix.
- Published in:
- Gynecologic & Obstetric Investigation, 2007, v. 64, n. 4, p. 193, doi. 10.1159/000106489
- By:
- Publication type:
- Article
Synthesis, Characterization, Pharmacokinetics and Evaluation of Cytotoxicity for Docetaxel-Oleate Conjugate Targeting MCF-7 Breast Cancer Cells.
- Published in:
- Pharmaceutical Chemistry Journal, 2018, v. 51, n. 11, p. 1005, doi. 10.1007/s11094-018-1730-8
- By:
- Publication type:
- Article
Optimizing Quality Control of Docetaxel Drug Substance and its Parenteral Dosage Forms.
- Published in:
- Pharmaceutical Chemistry Journal, 2013, v. 47, n. 9, p. 503, doi. 10.1007/s11094-013-0990-6
- By:
- Publication type:
- Article
Feasibility and efficacy of early docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in a rural health care setting.
- Published in:
- Scandinavian Journal of Urology, 2022, v. 56, n. 2, p. 114, doi. 10.1080/21681805.2022.2028006
- By:
- Publication type:
- Article
Soft Tissue Sarcomas: Insights from a Single-Center Retrospective Study.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 4, p. 269, doi. 10.14744/ejmi.2024.68903
- By:
- Publication type:
- Article
Prognostic Markers in the Treatment of Abiraterone Acetate + Prednisolone and Enzalutamide in Castration-Resistant Metastatic Prostate Cancer; Prognostic Value of Neutrophil Lymphocyte Ratio in Post - Docetaxel Setting.
- Published in:
- Eurasian Journal of Medical Investigation, 2022, p. 45, doi. 10.14744/ejmi.2022.22832
- By:
- Publication type:
- Article
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA).
- Published in:
- Breast Cancer Research Review, 2023, n. 40, p. 4
- By:
- Publication type:
- Article
Pathologie Response Rates in Patients with Gastric Cancer Following FLOT Neoadjuvant Chemotherapy.
- Published in:
- International Journal of Cancer Management, 2024, v. 17, n. 1, p. 1, doi. 10.5812/ijcm-139026
- By:
- Publication type:
- Article
Evaluation of Survival Rate and Non-Fetal Outcomes in Patients with Esophageal Cancer Under Treatment with Neoadjuvant Chemoradiotherapy Plus Additional Platinium-Based Chemotherapy from 2010 to 2016.
- Published in:
- International Journal of Cancer Management, 2019, v. 12, n. 6, p. 1, doi. 10.5812/ijcm.89003
- By:
- Publication type:
- Article
Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.
- Published in:
- Drug Metabolism Reviews, 2016, v. 48, n. 4, p. 502, doi. 10.1080/03602532.2016.1226896
- By:
- Publication type:
- Article
249. MECHANISM OF DIFFERENTIAL INDUCTION OF CYP3A BY TAXANE ANTICANCER AGENTS.
- Published in:
- 2002
- Publication type:
- Abstract
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.10280
- By:
- Publication type:
- Article
Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.10480
- By:
- Publication type:
- Article
Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
What Drives Diffusion of New Cancer Therapies?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 6, p. 2, doi. 10.1093/jnci/djv162
- By:
- Publication type:
- Article
The Diffusion of Docetaxel in Patients With Metastatic Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 2, p. 1, doi. 10.1093/jnci/dju412
- By:
- Publication type:
- Article
Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 22, p. 1729, doi. 10.1093/jnci/djt280
- By:
- Publication type:
- Article
PDQ (Physician Data Query).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 17, p. 1278, doi. 10.1093/jnci/djs390
- Publication type:
- Article
Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 7, p. 498, doi. 10.1093/jnci/djp007
- By:
- Publication type:
- Article
The Taxane Limbo: How Low Can We Go?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 11, p. 761, doi. 10.1093/jnci/djn155
- By:
- Publication type:
- Article
Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02-98 Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 2, p. 121
- By:
- Publication type:
- Article
Docetaxel Offers a More Effective but More Toxic Drug Regiment for Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 13, p. 957
- By:
- Publication type:
- Article
Phase III Randomized Trial of Docetaxel—Carboplatin Versus Paclitaxel—Carboplatin as First-line Chemotherapy for Ovarian Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 22, p. 1682
- By:
- Publication type:
- Article
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells1.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 542, doi. 10.1080/14756366.2021.2018684
- By:
- Publication type:
- Article
Enhanced anticancer efficacy of docetaxel through galbanic acid encapsulated into PLA-PEG nanoparticles in treatment of colon cancer, in vitro and in vivo study.
- Published in:
- Journal of Bioactive & Compatible Polymers, 2021, v. 36, n. 6, p. 520, doi. 10.1177/08839115211053922
- By:
- Publication type:
- Article
Docetaxel-loaded composite nanoparticles formed by a temperature-induced phase transition for cancer therapy.
- Published in:
- Journal of Bioactive & Compatible Polymers, 2012, v. 27, n. 5, p. 441, doi. 10.1177/0883911512448752
- By:
- Publication type:
- Article
GC-MS对多西他赛原料药中DMAP和DCC的残留检测.
- Published in:
- Journal of Pharmaceutical Practice & Service, 2018, v. 36, n. 5, p. 446, doi. 10.3969/j.issn.1006-0111.2018.05.014
- By:
- Publication type:
- Article
A New Look at Induction Chemotherapy in Locally Advanced Head and Neck Cancer.
- Published in:
- Oncologist, 2010, v. 15, p. 1, doi. 10.1634/theoncologist.2010-S3-01
- By:
- Publication type:
- Article
Induction Chemotherapy for Head and Neck Cancer: Recent Data.
- Published in:
- Oncologist, 2010, v. 15, p. 3, doi. 10.1634/theoncologist.2010-S3-03
- By:
- Publication type:
- Article
Induction Chemotherapy Before Chemoradiotherapy in Locally Advanced Head and Neck Cancer: The Future?
- Published in:
- Oncologist, 2010, v. 15, p. 8, doi. 10.1634/theoncologist.2010-S3-08
- By:
- Publication type:
- Article
TPF Sequential Therapy: When and for Whom?
- Published in:
- Oncologist, 2010, v. 15, p. 13, doi. 10.1634/theoncologist.2010-S3-13
- By:
- Publication type:
- Article
TPF: A Rational Choice for Larynx Preservation?
- Published in:
- Oncologist, 2010, v. 15, p. 19, doi. 10.1634/theoncologist.2010-S3-19
- By:
- Publication type:
- Article